RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial

• Status: Completed
• Trial end date: 2012-12-01

Summary

The purposes of this study are:

1. To evaluate the long-term safety of dabigatran etexilate

2. To assess the effect of a knowledge translation intervention on patient outcomes

• Phase: Phase 3

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Dabigatran